Réaction #2396836

ord-b6db2ee52bbb48b39a7ec7671174138f

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Températurerefluxed overnight
  2. 2
    AutreThe reaction mixture was evaporated
  3. 3
    AutreThe residue was purified by column chromatography over silica gel using first
  4. 4
    workup.ADDITIONa mixture of trichloromethane and methanol saturated with ammonia (97:3 by volume)
  5. 5
    workup.ADDITIONa mixture of trichloromethane and methanol saturated with ammonia (95:5 by volume) as eluent
  6. 6
    AutreThe pure fractions were collected
  7. 7
    Autrethe eluent was evaporated
  8. 8
    AutreThe residue was crystallized from 2-propanone

Mode opératoire

A mixture of 10.3 parts of 2-amino-N-[4-[4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]methyl]-1-piperidinyl]-butyl]benzamide, 3.2 parts of 1,1'-carbonylbis[1H-imidazole] and 180 parts of tetrahydrofuran was stirred and refluxed overnight. The reaction mixture was evaporated. The residue was purified by column chromatography over silica gel using first a mixture of trichloromethane and methanol saturated with ammonia (97:3 by volume) and then a mixture of trichloromethane and methanol saturated with ammonia (95:5 by volume) as eluent. The pure fractions were collected and the eluent was evaporated. The residue was crystallized from 2-propanone, yielding 3.8 parts (35.5%) of 3-[4-[4-[[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]methyl]-1-piperidinyl]butyl]-2,4(1H,3H)-quinazolinedione; mp. 187.3° C. (489).

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US04695575uspto-grants-1987_09